サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1389271

世界の汎用ペプチド市場：考察と予測 (2029年まで)

Global Generic Peptides Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 111 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の汎用ペプチド市場：考察と予測 (2029年まで)
出版日: 2023年12月04日
発行: QYResearch
ページ情報: 英文 111 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、汎用ペプチド (Generic Peptides) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 汎用ペプチドの製品概要
  • 市場：タイプ別
    • 世界の汎用ペプチドの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Hormone Analogs
    • Vasopressin Analogs
    • Calcitonin Generics
    • Other
  • 市場：用途別
    • 世界の汎用ペプチドの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Commercial Production
    • Scientific Research
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の汎用ペプチド売上予測・予想 2018-2029
  • 世界の汎用ペプチドの収益：地域別
    • 世界の汎用ペプチドの収益：地域別: 2018 VS 2022 VS 2029
    • 世界の汎用ペプチドの収益：地域別 (2018-2023)
    • 世界の汎用ペプチドの収益：地域別 (2024-2029)
    • 世界の汎用ペプチドの収益市場シェア 地域別 (2018-2029)
  • 世界の汎用ペプチド売上予測・予想 2018-2029
  • 世界の汎用ペプチドの販売：地域別
    • 世界の汎用ペプチドの販売：地域別: 2018 VS 2022 VS 2029
    • 世界の汎用ペプチドの販売：地域別 (2018-2023)
    • 世界の汎用ペプチドの販売：地域別 (2024-2029)
    • 世界の汎用ペプチドの販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の汎用ペプチドの販売：企業別
    • 世界の汎用ペプチドの販売：企業別 (2018-2023)
    • 世界の汎用ペプチドの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 汎用ペプチド in 2022
  • 世界の汎用ペプチドの収益：企業別
    • 世界の汎用ペプチドの収益：企業別 (2018-2023)
    • 世界の汎用ペプチドの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 汎用ペプチドの収益 2022
  • 世界の主要企業 汎用ペプチド, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の汎用ペプチドの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の汎用ペプチドの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 汎用ペプチド, 製造拠点分布と本社
  • 世界の主要メーカー 汎用ペプチド, 提供製品と用途
  • 世界の主要メーカー 汎用ペプチド, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の汎用ペプチドの販売：タイプ別
    • 世界の汎用ペプチドの販売実績：タイプ別 (2018-2023)
    • 世界の汎用ペプチドの販売予測：タイプ別 (2024-2029)
    • 世界の汎用ペプチドの販売市場シェア：タイプ別 (2018-2029)
  • 世界の汎用ペプチド 収益：タイプ別
    • 世界の汎用ペプチドの収益実績：タイプ別 (2018-2023)
    • 世界の汎用ペプチドの収益予測：タイプ別 (2024-2029)
    • 世界の汎用ペプチドの収益市場シェア：タイプ別 (2018-2029)
  • 世界の汎用ペプチドの価格：タイプ別
    • 世界の汎用ペプチドの価格：タイプ別 (2018-2023)
    • 世界の汎用ペプチドの価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界の汎用ペプチドの販売：用途別
    • 世界の汎用ペプチドの販売実績：用途別 (2018-2023)
    • 世界の汎用ペプチドの販売予測：用途別 (2024-2029)
    • 世界の汎用ペプチドの販売市場シェア：用途別 (2018-2029)
  • 世界の汎用ペプチドの収益：用途別
    • 世界の汎用ペプチドの収益実績：用途別 (2018-2023)
    • 世界の汎用ペプチドの収益予測：用途別 (2024-2029)
    • 世界の汎用ペプチドの収益市場シェア：用途別 (2018-2029)
  • 世界の汎用ペプチドの価格：用途別
    • 世界の汎用ペプチドの価格：用途別 (2018-2023)
    • 世界の汎用ペプチドの価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ 汎用ペプチド 市場規模：タイプ別
    • 米国・カナダ 汎用ペプチドの販売：タイプ別 (2018-2029)
    • 米国・カナダ 汎用ペプチド 収益：タイプ別 (2018-2029)
  • 米国・カナダ 汎用ペプチド 市場規模：用途別
    • 米国・カナダ 汎用ペプチドの販売：用途別 (2018-2029)
    • 米国・カナダ 汎用ペプチドの収益：用途別 (2018-2029)
  • 米国・カナダ 汎用ペプチド 市場規模：国別
    • 米国・カナダ 汎用ペプチドの収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ 汎用ペプチドの販売：国別 (2018-2029)
    • 米国・カナダ 汎用ペプチドの収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の汎用ペプチド 市場規模：タイプ別
    • 欧州の汎用ペプチドの販売：タイプ別 (2018-2029)
    • 欧州の汎用ペプチド 収益：タイプ別 (2018-2029)
  • 欧州の汎用ペプチド 市場規模：用途別
    • 欧州の汎用ペプチドの販売：用途別 (2018-2029)
    • 欧州の汎用ペプチドの収益：用途別 (2018-2029)
  • 欧州の汎用ペプチド 市場規模：国別
    • 欧州の汎用ペプチドの収益：国別: 2018 VS 2022 VS 2029
    • 欧州の汎用ペプチドの販売：国別 (2018-2029)
    • 欧州の汎用ペプチドの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の汎用ペプチド 市場規模
    • 中国の汎用ペプチド 売上 (2018-2029)
    • 中国の汎用ペプチド 収益 (2018-2029)
  • 中国の汎用ペプチド 市場規模：用途別
    • 中国の汎用ペプチドの販売：用途別 (2018-2029)
    • 中国の汎用ペプチドの収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 汎用ペプチド 市場規模：タイプ別
    • アジア地域 汎用ペプチドの販売：タイプ別 (2018-2029)
    • アジア地域 汎用ペプチド 収益：タイプ別 (2018-2029)
  • アジア地域 汎用ペプチド 市場規模：用途別
    • アジア地域 汎用ペプチドの販売：用途別 (2018-2029)
    • アジア地域 汎用ペプチドの収益：用途別 (2018-2029)
  • アジア地域 汎用ペプチドの販売：地域別
    • アジア地域 汎用ペプチドの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 汎用ペプチドの収益：地域別 (2018-2029)
    • アジア地域 汎用ペプチドの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの汎用ペプチド 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチド 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの汎用ペプチド 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの販売：国別
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの汎用ペプチドの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Bachem
  • PolyPeptide
  • AmbioPharm
  • CordenPharma
  • USV Peptides
  • ScinoPharm
  • Piramal Pharma Solutions
  • CPC Scientific
  • Dr. Reddy's Laboratories
  • Omgene Life Sciences
  • ANYGEN
  • BCN Peptides
  • Amphastar Pharmaceuticals

第12章 業界チェーンと販売チャネルの分析

  • 汎用ペプチド 業界チェーン分析
  • 汎用ペプチド 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 汎用ペプチド 生産形態とプロセス
  • 汎用ペプチド 販売およびマーケティング
    • 汎用ペプチド 販売チャネルs
    • 汎用ペプチド 卸業者
  • 汎用ペプチド 顧客

第13章 市場動向

  • 汎用ペプチド 業界動向
  • 汎用ペプチド 市場の促進要因
  • 汎用ペプチド 市場の課題
  • 汎用ペプチド 市場の抑制要因

第14章 主な調査結果 世界の汎用ペプチドの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Hormone Analogs
  • Table 3. Major Manufacturers of Vasopressin Analogs
  • Table 4. Major Manufacturers of Calcitonin Generics
  • Table 5. Major Manufacturers of Other
  • Table 6. Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 7. Global Generic Peptides Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 8. Global Generic Peptides Revenue by Region (2018-2023) & (US$ Million)
  • Table 9. Global Generic Peptides Revenue by Region (2024-2029) & (US$ Million)
  • Table 10. Global Generic Peptides Revenue Market Share by Region (2018-2023)
  • Table 11. Global Generic Peptides Revenue Market Share by Region (2024-2029)
  • Table 12. Global Generic Peptides Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 13. Global Generic Peptides Sales by Region (2018-2023) & (K Units)
  • Table 14. Global Generic Peptides Sales by Region (2024-2029) & (K Units)
  • Table 15. Global Generic Peptides Sales Market Share by Region (2018-2023)
  • Table 16. Global Generic Peptides Sales Market Share by Region (2024-2029)
  • Table 17. Global Generic Peptides Sales by Manufacturers (2018-2023) & (K Units)
  • Table 18. Global Generic Peptides Sales Share by Manufacturers (2018-2023)
  • Table 19. Global Generic Peptides Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 20. Global Generic Peptides Revenue Share by Manufacturers (2018-2023)
  • Table 21. Global Key Players of Generic Peptides, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 22. Generic Peptides Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 23. Global Generic Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 24. Global Generic Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Peptides as of 2022)
  • Table 25. Global Key Manufacturers of Generic Peptides, Manufacturing Base Distribution and Headquarters
  • Table 26. Global Key Manufacturers of Generic Peptides, Product Offered and Application
  • Table 27. Global Key Manufacturers of Generic Peptides, Date of Enter into This Industry
  • Table 28. Mergers & Acquisitions, Expansion Plans
  • Table 29. Global Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 30. Global Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 31. Global Generic Peptides Sales Share by Type (2018-2023)
  • Table 32. Global Generic Peptides Sales Share by Type (2024-2029)
  • Table 33. Global Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 34. Global Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 35. Global Generic Peptides Revenue Share by Type (2018-2023)
  • Table 36. Global Generic Peptides Revenue Share by Type (2024-2029)
  • Table 37. Generic Peptides Price by Type (2018-2023) & (US$/Unit)
  • Table 38. Global Generic Peptides Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 39. Global Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 40. Global Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 41. Global Generic Peptides Sales Share by Application (2018-2023)
  • Table 42. Global Generic Peptides Sales Share by Application (2024-2029)
  • Table 43. Global Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 44. Global Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 45. Global Generic Peptides Revenue Share by Application (2018-2023)
  • Table 46. Global Generic Peptides Revenue Share by Application (2024-2029)
  • Table 47. Generic Peptides Price by Application (2018-2023) & (US$/Unit)
  • Table 48. Global Generic Peptides Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 49. US & Canada Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 50. US & Canada Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 51. US & Canada Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 52. US & Canada Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 53. US & Canada Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 54. US & Canada Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 55. US & Canada Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 56. US & Canada Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 57. US & Canada Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 58. US & Canada Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
  • Table 59. US & Canada Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
  • Table 60. US & Canada Generic Peptides Sales by Country (2018-2023) & (K Units)
  • Table 61. US & Canada Generic Peptides Sales by Country (2024-2029) & (K Units)
  • Table 62. Europe Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 63. Europe Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 64. Europe Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 65. Europe Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 66. Europe Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 67. Europe Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 68. Europe Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 69. Europe Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 70. Europe Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 71. Europe Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
  • Table 72. Europe Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
  • Table 73. Europe Generic Peptides Sales by Country (2018-2023) & (K Units)
  • Table 74. Europe Generic Peptides Sales by Country (2024-2029) & (K Units)
  • Table 75. China Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 76. China Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 77. China Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 78. China Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 79. China Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 80. China Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 81. China Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 82. China Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 83. Asia Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 84. Asia Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 85. Asia Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 86. Asia Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 87. Asia Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 88. Asia Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 89. Asia Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 90. Asia Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 91. Asia Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 92. Asia Generic Peptides Revenue by Region (2018-2023) & (US$ Million)
  • Table 93. Asia Generic Peptides Revenue by Region (2024-2029) & (US$ Million)
  • Table 94. Asia Generic Peptides Sales by Region (2018-2023) & (K Units)
  • Table 95. Asia Generic Peptides Sales by Region (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Generic Peptides Sales by Type (2018-2023) & (K Units)
  • Table 97. Middle East, Africa and Latin America Generic Peptides Sales by Type (2024-2029) & (K Units)
  • Table 98. Middle East, Africa and Latin America Generic Peptides Revenue by Type (2018-2023) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Generic Peptides Revenue by Type (2024-2029) & (US$ Million)
  • Table 100. Middle East, Africa and Latin America Generic Peptides Sales by Application (2018-2023) & (K Units)
  • Table 101. Middle East, Africa and Latin America Generic Peptides Sales by Application (2024-2029) & (K Units)
  • Table 102. Middle East, Africa and Latin America Generic Peptides Revenue by Application (2018-2023) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Generic Peptides Revenue by Application (2024-2029) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Generic Peptides Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 105. Middle East, Africa and Latin America Generic Peptides Revenue by Country (2018-2023) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Generic Peptides Revenue by Country (2024-2029) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Generic Peptides Sales by Country (2018-2023) & (K Units)
  • Table 108. Middle East, Africa and Latin America Generic Peptides Sales by Country (2024-2029) & (K Units)
  • Table 109. Bachem Company Information
  • Table 110. Bachem Description and Major Businesses
  • Table 111. Bachem Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 112. Bachem Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 113. Bachem Recent Developments
  • Table 114. PolyPeptide Company Information
  • Table 115. PolyPeptide Description and Major Businesses
  • Table 116. PolyPeptide Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 117. PolyPeptide Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 118. PolyPeptide Recent Developments
  • Table 119. AmbioPharm Company Information
  • Table 120. AmbioPharm Description and Major Businesses
  • Table 121. AmbioPharm Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 122. AmbioPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 123. AmbioPharm Recent Developments
  • Table 124. CordenPharma Company Information
  • Table 125. CordenPharma Description and Major Businesses
  • Table 126. CordenPharma Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 127. CordenPharma Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 128. CordenPharma Recent Developments
  • Table 129. USV Peptides Company Information
  • Table 130. USV Peptides Description and Major Businesses
  • Table 131. USV Peptides Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 132. USV Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 133. USV Peptides Recent Developments
  • Table 134. ScinoPharm Company Information
  • Table 135. ScinoPharm Description and Major Businesses
  • Table 136. ScinoPharm Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 137. ScinoPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 138. ScinoPharm Recent Developments
  • Table 139. Piramal Pharma Solutions Company Information
  • Table 140. Piramal Pharma Solutions Description and Major Businesses
  • Table 141. Piramal Pharma Solutions Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 142. Piramal Pharma Solutions Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. Piramal Pharma Solutions Recent Developments
  • Table 144. CPC Scientific Company Information
  • Table 145. CPC Scientific Description and Major Businesses
  • Table 146. CPC Scientific Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 147. CPC Scientific Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. CPC Scientific Recent Developments
  • Table 149. Dr. Reddy's Laboratories Company Information
  • Table 150. Dr. Reddy's Laboratories Description and Major Businesses
  • Table 151. Dr. Reddy's Laboratories Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 152. Dr. Reddy's Laboratories Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 153. Dr. Reddy's Laboratories Recent Developments
  • Table 154. Omgene Life Sciences Company Information
  • Table 155. Omgene Life Sciences Description and Major Businesses
  • Table 156. Omgene Life Sciences Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 157. Omgene Life Sciences Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 158. Omgene Life Sciences Recent Developments
  • Table 159. ANYGEN Company Information
  • Table 160. ANYGEN Description and Major Businesses
  • Table 161. ANYGEN Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 162. ANYGEN Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 163. ANYGEN Recent Developments
  • Table 164. BCN Peptides Company Information
  • Table 165. BCN Peptides Description and Major Businesses
  • Table 166. BCN Peptides Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 167. BCN Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 168. BCN Peptides Recent Developments
  • Table 169. Amphastar Pharmaceuticals Company Information
  • Table 170. Amphastar Pharmaceuticals Description and Major Businesses
  • Table 171. Amphastar Pharmaceuticals Generic Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 172. Amphastar Pharmaceuticals Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 173. Amphastar Pharmaceuticals Recent Developments
  • Table 174. Key Raw Materials Lists
  • Table 175. Raw Materials Key Suppliers Lists
  • Table 176. Generic Peptides Distributors List
  • Table 177. Generic Peptides Customers List
  • Table 178. Generic Peptides Market Trends
  • Table 179. Generic Peptides Market Drivers
  • Table 180. Generic Peptides Market Challenges
  • Table 181. Generic Peptides Market Restraints
  • Table 182. Research Programs/Design for This Report
  • Table 183. Key Data Information from Secondary Sources
  • Table 184. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Generic Peptides Product Picture
  • Figure 2. Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Generic Peptides Market Share by Type in 2022 & 2029
  • Figure 4. Hormone Analogs Product Picture
  • Figure 5. Vasopressin Analogs Product Picture
  • Figure 6. Calcitonin Generics Product Picture
  • Figure 7. Other Product Picture
  • Figure 8. Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 9. Global Generic Peptides Market Share by Application in 2022 & 2029
  • Figure 10. Commercial Production
  • Figure 11. Scientific Research
  • Figure 12. Other
  • Figure 13. Generic Peptides Report Years Considered
  • Figure 14. Global Generic Peptides Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Generic Peptides Revenue 2018-2029 (US$ Million)
  • Figure 16. Global Generic Peptides Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 17. Global Generic Peptides Revenue Market Share by Region (2018-2029)
  • Figure 18. Global Generic Peptides Sales 2018-2029 ((K Units)
  • Figure 19. Global Generic Peptides Sales Market Share by Region (2018-2029)
  • Figure 20. US & Canada Generic Peptides Sales YoY (2018-2029) & (K Units)
  • Figure 21. US & Canada Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. Europe Generic Peptides Sales YoY (2018-2029) & (K Units)
  • Figure 23. Europe Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. China Generic Peptides Sales YoY (2018-2029) & (K Units)
  • Figure 25. China Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Asia (excluding China) Generic Peptides Sales YoY (2018-2029) & (K Units)
  • Figure 27. Asia (excluding China) Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Middle East, Africa and Latin America Generic Peptides Sales YoY (2018-2029) & (K Units)
  • Figure 29. Middle East, Africa and Latin America Generic Peptides Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. The Generic Peptides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 31. The Top 5 and 10 Largest Manufacturers of Generic Peptides in the World: Market Share by Generic Peptides Revenue in 2022
  • Figure 32. Global Generic Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 33. Global Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 34. Global Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 35. Global Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 36. Global Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 37. US & Canada Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 38. US & Canada Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 39. US & Canada Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 40. US & Canada Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 41. US & Canada Generic Peptides Revenue Share by Country (2018-2029)
  • Figure 42. US & Canada Generic Peptides Sales Share by Country (2018-2029)
  • Figure 43. U.S. Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 44. Canada Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 45. Europe Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 46. Europe Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 47. Europe Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 48. Europe Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 49. Europe Generic Peptides Revenue Share by Country (2018-2029)
  • Figure 50. Europe Generic Peptides Sales Share by Country (2018-2029)
  • Figure 51. Germany Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 52. France Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 53. U.K. Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 54. Italy Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 55. Russia Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 56. China Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 57. China Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 58. China Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 59. China Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 60. Asia Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 61. Asia Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 62. Asia Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 63. Asia Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 64. Asia Generic Peptides Revenue Share by Region (2018-2029)
  • Figure 65. Asia Generic Peptides Sales Share by Region (2018-2029)
  • Figure 66. Japan Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 67. South Korea Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 68. China Taiwan Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 69. Southeast Asia Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 70. India Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 71. Middle East, Africa and Latin America Generic Peptides Sales Market Share by Type (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Generic Peptides Revenue Market Share by Type (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Generic Peptides Sales Market Share by Application (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Generic Peptides Revenue Market Share by Application (2018-2029)
  • Figure 75. Middle East, Africa and Latin America Generic Peptides Revenue Share by Country (2018-2029)
  • Figure 76. Middle East, Africa and Latin America Generic Peptides Sales Share by Country (2018-2029)
  • Figure 77. Brazil Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 78. Mexico Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 79. Turkey Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 80. Israel Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 81. GCC Countries Generic Peptides Revenue (2018-2029) & (US$ Million)
  • Figure 82. Generic Peptides Value Chain
  • Figure 83. Generic Peptides Production Process
  • Figure 84. Channels of Distribution
  • Figure 85. Distributors Profiles
  • Figure 86. Bottom-up and Top-down Approaches for This Report
  • Figure 87. Data Triangulation
  • Figure 88. Key Executives Interviewed
目次

This research report focuses on the Generic Peptides Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Generic Peptides Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Generic Peptides Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Hormone Analogs
    • 1.2.3 Vasopressin Analogs
    • 1.2.4 Calcitonin Generics
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Generic Peptides Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Commercial Production
    • 1.3.3 Scientific Research
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Generic Peptides Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Generic Peptides Revenue by Region
    • 2.2.1 Global Generic Peptides Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Generic Peptides Revenue by Region (2018-2023)
    • 2.2.3 Global Generic Peptides Revenue by Region (2024-2029)
    • 2.2.4 Global Generic Peptides Revenue Market Share by Region (2018-2029)
  • 2.3 Global Generic Peptides Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Generic Peptides Sales by Region
    • 2.4.1 Global Generic Peptides Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Generic Peptides Sales by Region (2018-2023)
    • 2.4.3 Global Generic Peptides Sales by Region (2024-2029)
    • 2.4.4 Global Generic Peptides Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Generic Peptides Sales by Manufacturers
    • 3.1.1 Global Generic Peptides Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Generic Peptides Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Peptides in 2022
  • 3.2 Global Generic Peptides Revenue by Manufacturers
    • 3.2.1 Global Generic Peptides Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Generic Peptides Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Generic Peptides Revenue in 2022
  • 3.3 Global Key Players of Generic Peptides, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Generic Peptides Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Generic Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Generic Peptides, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Generic Peptides, Product Offered and Application
  • 3.8 Global Key Manufacturers of Generic Peptides, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Generic Peptides Sales by Type
    • 4.1.1 Global Generic Peptides Historical Sales by Type (2018-2023)
    • 4.1.2 Global Generic Peptides Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Generic Peptides Sales Market Share by Type (2018-2029)
  • 4.2 Global Generic Peptides Revenue by Type
    • 4.2.1 Global Generic Peptides Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Generic Peptides Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Generic Peptides Revenue Market Share by Type (2018-2029)
  • 4.3 Global Generic Peptides Price by Type
    • 4.3.1 Global Generic Peptides Price by Type (2018-2023)
    • 4.3.2 Global Generic Peptides Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Generic Peptides Sales by Application
    • 5.1.1 Global Generic Peptides Historical Sales by Application (2018-2023)
    • 5.1.2 Global Generic Peptides Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Generic Peptides Sales Market Share by Application (2018-2029)
  • 5.2 Global Generic Peptides Revenue by Application
    • 5.2.1 Global Generic Peptides Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Generic Peptides Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Generic Peptides Revenue Market Share by Application (2018-2029)
  • 5.3 Global Generic Peptides Price by Application
    • 5.3.1 Global Generic Peptides Price by Application (2018-2023)
    • 5.3.2 Global Generic Peptides Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Generic Peptides Market Size by Type
    • 6.1.1 US & Canada Generic Peptides Sales by Type (2018-2029)
    • 6.1.2 US & Canada Generic Peptides Revenue by Type (2018-2029)
  • 6.2 US & Canada Generic Peptides Market Size by Application
    • 6.2.1 US & Canada Generic Peptides Sales by Application (2018-2029)
    • 6.2.2 US & Canada Generic Peptides Revenue by Application (2018-2029)
  • 6.3 US & Canada Generic Peptides Market Size by Country
    • 6.3.1 US & Canada Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Generic Peptides Sales by Country (2018-2029)
    • 6.3.3 US & Canada Generic Peptides Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Generic Peptides Market Size by Type
    • 7.1.1 Europe Generic Peptides Sales by Type (2018-2029)
    • 7.1.2 Europe Generic Peptides Revenue by Type (2018-2029)
  • 7.2 Europe Generic Peptides Market Size by Application
    • 7.2.1 Europe Generic Peptides Sales by Application (2018-2029)
    • 7.2.2 Europe Generic Peptides Revenue by Application (2018-2029)
  • 7.3 Europe Generic Peptides Market Size by Country
    • 7.3.1 Europe Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Generic Peptides Sales by Country (2018-2029)
    • 7.3.3 Europe Generic Peptides Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Generic Peptides Market Size
    • 8.1.1 China Generic Peptides Sales (2018-2029)
    • 8.1.2 China Generic Peptides Revenue (2018-2029)
  • 8.2 China Generic Peptides Market Size by Application
    • 8.2.1 China Generic Peptides Sales by Application (2018-2029)
    • 8.2.2 China Generic Peptides Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Generic Peptides Market Size by Type
    • 9.1.1 Asia Generic Peptides Sales by Type (2018-2029)
    • 9.1.2 Asia Generic Peptides Revenue by Type (2018-2029)
  • 9.2 Asia Generic Peptides Market Size by Application
    • 9.2.1 Asia Generic Peptides Sales by Application (2018-2029)
    • 9.2.2 Asia Generic Peptides Revenue by Application (2018-2029)
  • 9.3 Asia Generic Peptides Sales by Region
    • 9.3.1 Asia Generic Peptides Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Generic Peptides Revenue by Region (2018-2029)
    • 9.3.3 Asia Generic Peptides Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Generic Peptides Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Generic Peptides Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Generic Peptides Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Generic Peptides Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Generic Peptides Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Generic Peptides Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Generic Peptides Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Generic Peptides Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Generic Peptides Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Generic Peptides Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Bachem
    • 11.1.1 Bachem Company Information
    • 11.1.2 Bachem Overview
    • 11.1.3 Bachem Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Bachem Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bachem Recent Developments
  • 11.2 PolyPeptide
    • 11.2.1 PolyPeptide Company Information
    • 11.2.2 PolyPeptide Overview
    • 11.2.3 PolyPeptide Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 PolyPeptide Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 PolyPeptide Recent Developments
  • 11.3 AmbioPharm
    • 11.3.1 AmbioPharm Company Information
    • 11.3.2 AmbioPharm Overview
    • 11.3.3 AmbioPharm Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 AmbioPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 AmbioPharm Recent Developments
  • 11.4 CordenPharma
    • 11.4.1 CordenPharma Company Information
    • 11.4.2 CordenPharma Overview
    • 11.4.3 CordenPharma Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 CordenPharma Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 CordenPharma Recent Developments
  • 11.5 USV Peptides
    • 11.5.1 USV Peptides Company Information
    • 11.5.2 USV Peptides Overview
    • 11.5.3 USV Peptides Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 USV Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 USV Peptides Recent Developments
  • 11.6 ScinoPharm
    • 11.6.1 ScinoPharm Company Information
    • 11.6.2 ScinoPharm Overview
    • 11.6.3 ScinoPharm Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 ScinoPharm Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 ScinoPharm Recent Developments
  • 11.7 Piramal Pharma Solutions
    • 11.7.1 Piramal Pharma Solutions Company Information
    • 11.7.2 Piramal Pharma Solutions Overview
    • 11.7.3 Piramal Pharma Solutions Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Piramal Pharma Solutions Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Piramal Pharma Solutions Recent Developments
  • 11.8 CPC Scientific
    • 11.8.1 CPC Scientific Company Information
    • 11.8.2 CPC Scientific Overview
    • 11.8.3 CPC Scientific Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 CPC Scientific Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 CPC Scientific Recent Developments
  • 11.9 Dr. Reddy's Laboratories
    • 11.9.1 Dr. Reddy's Laboratories Company Information
    • 11.9.2 Dr. Reddy's Laboratories Overview
    • 11.9.3 Dr. Reddy's Laboratories Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Dr. Reddy's Laboratories Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Dr. Reddy's Laboratories Recent Developments
  • 11.10 Omgene Life Sciences
    • 11.10.1 Omgene Life Sciences Company Information
    • 11.10.2 Omgene Life Sciences Overview
    • 11.10.3 Omgene Life Sciences Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Omgene Life Sciences Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Omgene Life Sciences Recent Developments
  • 11.11 ANYGEN
    • 11.11.1 ANYGEN Company Information
    • 11.11.2 ANYGEN Overview
    • 11.11.3 ANYGEN Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 ANYGEN Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 ANYGEN Recent Developments
  • 11.12 BCN Peptides
    • 11.12.1 BCN Peptides Company Information
    • 11.12.2 BCN Peptides Overview
    • 11.12.3 BCN Peptides Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 BCN Peptides Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 BCN Peptides Recent Developments
  • 11.13 Amphastar Pharmaceuticals
    • 11.13.1 Amphastar Pharmaceuticals Company Information
    • 11.13.2 Amphastar Pharmaceuticals Overview
    • 11.13.3 Amphastar Pharmaceuticals Generic Peptides Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Amphastar Pharmaceuticals Generic Peptides Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Amphastar Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Generic Peptides Industry Chain Analysis
  • 12.2 Generic Peptides Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Generic Peptides Production Mode & Process
  • 12.4 Generic Peptides Sales and Marketing
    • 12.4.1 Generic Peptides Sales Channels
    • 12.4.2 Generic Peptides Distributors
  • 12.5 Generic Peptides Customers

13 Market Dynamics

  • 13.1 Generic Peptides Industry Trends
  • 13.2 Generic Peptides Market Drivers
  • 13.3 Generic Peptides Market Challenges
  • 13.4 Generic Peptides Market Restraints

14 Key Findings in The Global Generic Peptides Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer